Regenosca

Switzerland
Malters, Lucerne, Switzerland, 1004

Company profile

Regenosca company profile

Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair. Regenosca brings regeneration over scarring with our medical devices.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2019-01-10

Headquarters

Postal code
1004
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
5
Total equity funding
$1.3M
Last funding
Pre Seed / $1.1M / 2024-07-22
Last equity funding
Pre Seed / $1.1M
Investors
4
Lead investors
2
Founders
1
Articles
7

Founders and investors

Founders

Eva-Maria Balet

Lead investors

Foundation for Innovation and Technology (FIT)Venture Kick

Investors

Business Angels Switzerland (BAS)Foundation for Innovation and Technology (FIT)MassChallengeVenture Kick